This study is a Phase I study, which is evaluating the investigational drug's safety, as well as how the drug works in humans. All investigational drugs must be tested in clinical research studies before they are approved and available to be prescribed by doctors. Clinical research studies are also reviewed and monitored by an Institutional Review Board (IRB), which makes sure that the rights of participants are protected and that there are no unnecessary risks involved in the study.